New Calamos ETF promises ‘100% downside protection.’ How it works


All the good, none of the bad? New funds, new promise

A new ETF designed to shield investors from the risk of market volatility starts trading on Wednesday. 

The Calamos S&P 500 Structured Alt Protection ETF (CPSM) promises to deliver investors “100% downside protection” against the index’s losses over a one-year outcome period, according the firm’s news release.

Calamos’ head of ETFs Matt Kaufman helped build the new product.

“There’s no tricks. There’s no magic,” he told CNBC’s “ETF Edge” on Monday. “This is the secret sauce.”

Kaufman explained the new ETF enters into three options positions. Investors in the fund are subject to limits on the extent to which they can capture gains tied to the S&P 500.

“They all work together. It’s a fully funded options package that delivers the upside of the S&P 500 to a cap with 100% capital protection over a 365-day outcome period,” he said. “Then at the end of that year, the options reset, stay in the ETF and keep on going.”

The fund will have an annual expense ratio of 0.69%.

In order to receive the full downside protection against losses in the S&P 500 that the fund promises, Kaufman noted investors must buy it Wednesday when it hits the market.

“If you buy in on day one, you get that 100% protection,” he said. “[But] even day two [or] day three, there’s probably opportunities to buy in all along the way.”

The fund is just one of a suite of 12 structured protection ETFs the firm plans to launch over the course of the next year. Upcoming funds include those aiming to protect against losses tied to the Nasdaq 100 and Russell 2000 benchmarks. 

Disclaimer



View Original Source Here

You May Also Like

West Coast ports shut down as union workers ‘no show’ after breakdown in wage negotiations

Shipping containers are seen at a terminal inside the Port of Oakland.…

Starbucks shares fall despite higher forecast as investors worry about international growth

In this article SBUX Starbucks’ president and CEO Kevin Johnson speaks during…

U.S. is ready to roll out J&J vaccine ‘without delay,’ pending FDA clearance, Biden health officials say

A healthcare worker holds a dose of the Johnson & Johnson vaccine…

Systemic racism slows down economic growth, Dallas Fed chief says

FILE PHOTO: Dallas Federal Reserve Bank President Robert Kaplan speaks at the…